BrainsWay Deep TMS - Innovative, Noninvasive Treatment

Elevate Mental Health Treatment with BrainsWay Deep TMS™

BrainsWay is excited to launch its Investigator Initiated Study (IIS) Program, designed to support further research on Deep TMS™ by the clinical research community through data collaboration and equipment loan initiatives.  Apply Now.

About Us

Who is BrainsWay?

A global medical technology company, BrainsWay focuses on developing cutting-edge medical devices that help advance the field of mental healthcare. Our advanced flagship technology of Deep Transcranial Magnetic Stimulation (Deep TMS™) is expanding the treatment of mental health beyond what was thought possible.

Deep TMS treatment has been proven to offer significant results by directly stimulating deeper and broader areas of the brain, effectively treating conditions such as depression, anxious depression, obsessive-compulsive disorder, and smoking addiction.

With numerous clinical studies and a growing number of patients and healthcare providers attesting to its success, BrainsWay Deep TMS is boldly advancing the treatment of mental health disorders.

Learn more about TMS

A Message to Our Customers About COVID-19


Top 6 Questions and Concerns About Offering Deep TMS
Two BrainsWay providers address common clinical, operational, and financial questions and concerns that providers often have when considering adding Deep TMS to their practice.


What do we treat?

BrainsWay’s innovative treatment has been proven beneficial in treating a number of mental health conditions, thanks to its safety and efficacy.

For Patients
Check out all of our treatments that we offer to help you be the best you can be.
For Healthcare Providers
We can help healthcare providers with our clinically proven technology.

Featured Treatments

Major Depressive Disorder (MDD) treatment
BrainsWay’s safe and effective Deep TMS is FDA-cleared to treat major depressive disorder (depression), offering patients a better quality of life.

Anxious Depression treatment
Our most recent FDA clearance is for the safe and effective reduction of comorbid anxiety symptoms in adult patients with depression.

Obsessive-Compulsive Disorder (OCD) treatment
BrainsWay introduces the first FDA-cleared (de novo) noninvasive medical device for the treatment of OCD.

Smoking Addiction treatment
BrainsWay’s latest treatment offering for short-term smoking cessation in adults, representing the first FDA clearance in the addiction space for any TMS device.

TMS Therapy

Our Treatments

Individuals looking for a treatment that works, and particularly treatment-resistant patients, can finally find relief thanks to BrainsWay Deep TMS:

View Our Treatments

Patients & Healthcare Providers

How does Deep TMS work?

BrainsWay has revolutionized the treatment of depression, OCD, and smoking addiction. With BrainsWay’s unique treatment, you can regain a sense of well-being and enjoy a better quality of life in just a few weeks.

It starts here.
Learn how it works

Patient Consultation for Deep TMS Treatment

Patients & Healthcare Providers

How do we help?

BrainsWay seeks to ensure that mental health providers, referral partners, and patients have the support necessary to achieve their goals.

We’re here for you.
Learn how we help you

Brainsway TMS

Clinically Proven Efficacy

From numerous studies to gaining FDA clearance and the European CE mark, BrainsWay’s safe and effective Deep TMS treatment is at the forefront of mental health treatments that are offering patients a brighter future.

Patient FAQs
Healthcare Professionals FAQs
Knowledge Center

Find A Deep TMS Provider Near You

With more than 600 providers, BrainsWay can provide the care you need.

Find a Provider

News & Events

See all the latest news, events and in the media BrainsWay has to offer and everything in-between.

May 23, 2023

BrainsWay Announces Appointment of Ido Marom as CFO

BURLINGTON, Mass. and JERUSALEM, May 23, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

May 23, 2023

Deep TMS improves quality of life in treatment-resistant depression

For patients with treatment-resistant major depressive disorder, deep transcranial magnetic stimulation...

September 28 - October 1, 2023

World Congress of Psychiatry Conference

BrainsWay is attending the World Congress of Psychiatry Conference from September 28 to October 1, 2003,...

Recent Articles

See all the latest mental health education articles and FAQs from BrainsWay.